Position in MRK
as of Jun 30, 2026
· filed Aug 10, 2026
Position Value
$78,206,128
+$41,655,290 QoQ
Shares Held
608,608
+100.3% QoQ
Ownership
0.025%
of shares outstanding
% of Portfolio
0.90%
of 13F equity value
Holder Rank
#238
of 3,769 holders
Holding Since
Mar 2020
25 quarters on record
Voting authority
Sole 33%
Shared 0%
None 67%
Common Shares in MRK Over Time
Shares Held
Position Value (USD)
Position in Drug Manufacturers - General
Healthcare · as of Jun 30, 2026Arax Advisory Partners holds $367,571,362 across 18 Drug Manufacturers - General names. MRK ranks #2 (21.3% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | JNJ |
Johnson & Johnson
|
326,790 | $82,994,856 | |
| 2 | MRK |
Merck & Co., Inc.
This page
|
608,608 | $78,206,128 | |
| 3 | LLY |
ELI LILLY & Co
|
46,821 | $56,158,516 | |
| 4 | ABBV |
AbbVie Inc.
|
164,897 | $41,494,681 | |
| 5 | NVO |
Novo Nordisk A S
|
449,006 | $21,525,347 | |
| 6 | BMY |
Bristol Myers Squibb Co
|
363,882 | $20,966,880 | |
| 7 | PFE |
Pfizer Inc
|
811,104 | $19,531,384 | |
| 8 | AMGN |
Amgen Inc
|
50,310 | $18,218,257 |
All Filings in MRK
Export CSV
25 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $78,206,128 | 608,608 | Shares | Sole | 2026-08-10 | |
| 2026-03-31 | $36,550,838 | 303,856 | Shares | Sole | 2026-05-13 | |
| 2025-12-31 | $30,938,966 | 293,929 | Shares | Sole | 2026-02-13 | |
| 2025-09-30 | $36,030,057 | 429,287 | Shares | Sole | 2025-11-14 | |
| 2025-06-30 | $22,413,520 | 283,142 | Shares | Sole | 2025-08-12 | |
| 2025-03-31 | $1,100,546 | 12,261 | Shares | Sole | 2025-05-15 | |
| 2024-12-31 | $655,075 | 6,585 | Shares | Sole | 2025-02-05 | |
| 2024-09-30 | $727,351 | 6,405 | Shares | Sole | 2024-11-06 | |
| 2024-06-30 | $761,121 | 6,148 | Shares | Sole | 2024-08-06 | |
| 2024-03-31 | $694,452 | 5,263 | Shares | Sole | 2024-05-14 | |
| 2023-12-31 | $549,132 | 5,037 | Shares | Sole | 2024-02-06 | |
| 2023-09-30 | $510,219 | 4,956 | Shares | Sole | 2023-11-14 | |
| 2023-06-30 | $584,911 | 5,069 | Shares | Sole | 2023-08-14 | |
| 2023-03-31 | $530,566 | 4,987 | Shares | Sole | 2023-05-16 | |
| 2022-12-31 | $555,304 | 5,005 | Shares | Sole | 2023-02-24 | |
| 2022-09-30 | $393,568 | 4,570 | Shares | Sole | 2022-11-03 | |
| 2022-06-30 | $456,305 | 5,005 | Shares | Sole | 2022-08-22 | |
| 2022-03-31 | $359,050 | 4,376 | Shares | Sole | 2022-05-12 | |
| 2021-12-31 | $371,780 | 4,851 | Shares | Sole | 2022-02-08 | |
| 2021-09-30 | $364,058 | 4,847 | Shares | Sole | 2021-11-05 | |
| 2021-06-30 | $295,681 | 3,802 | Shares | Sole | 2021-08-02 | |
| 2020-12-31 | $259,633 | 3,174 | Shares | Sole | 2021-02-03 | |
| 2020-09-30 | $254,324 | 3,066 | Shares | Sole | 2020-11-12 | |
| 2020-06-30 | $365,384 | 4,725 | Shares | Sole | 2020-08-06 | |
| 2020-03-31 | $363,156 | 4,720 | Shares | Sole | 2020-05-13 | |
| No filing history on record for this holder in this stock. | ||||||